Rivaroxaban
Rivaroxaban is an anticoagulant medication used to prevent and treat blood clots. It is commonly prescribed to reduce the risk of stroke and deep vein thrombosis. The medication works by inhibiting Factor Xa, an essential protein in the blood coagulation process. Available in tablet form, Rivaroxaban provides a convenient oral option for managing clot-related conditions. It is often used in patients with atrial fibrillation and after certain surgeries to prevent clot formation. The tablets offer a predictable response without the need for regular monitoring. Consult with a healthcare provider for the correct dosage and duration of therapy.Active substance:
RivaroxabanPharmachologic effect:
Rivaroxaban is an anticoagulant that works by inhibiting Factor Xa, an important component in the blood coagulation process, thereby preventing the formation of blood clots.Indications:
- Prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation
- Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE)
- Prevention of recurrent DVT and PE
- Prevention of venous thromboembolism (VTE) in patients undergoing hip or knee replacement surgery
Contraindications:
- Hypersensitivity to rivaroxaban or any of the excipients
- Active clinically significant bleeding
- Lesions or conditions at significant risk of major bleeding
- Hepatic disease associated with coagulopathy and clinically relevant bleeding risk
- Pregnancy and lactation
Side effects:
In order of decreasing probability: Common: bleeding events, anemia, nausea, Uncommon: thrombocytopenia, allergic reactions, dizziness, Rare: jaundice, elevated liver enzymes, hypersensitivity reactions
Dosing and Administration:
The recommended dose for prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation is 20 mg once daily with food. For the treatment of DVT and PE, the recommended dose is 15 mg twice daily for the first 21 days, followed by 20 mg once daily. For prevention of recurrent DVT and PE, the recommended dose is 20 mg once daily. For prevention of VTE in patients undergoing hip or knee replacement surgery, the recommended dose is 10 mg once daily.
Storage:
Store at a temperature not exceeding 30°C (86°F).
Rivaroxaban
in Cyrillic : Ривароксабан
SUBSTANCE
Rivaroxaban
DOSAGE FORM
tablets
MANUFACTURER
In Stock
available pack options :
| 20mg x 98 tablets | $230.40 | |
| 20mg x 28 tablets | $105.30 | |
| 2.5mg x 98 tablets | $163.20 | |
| 15mg x 98 tablets | $230.60 | |
| 2.5mg x 56 tablets | $112.30 |
